Bone Marrow TransplantationBone MarrowTransplantation, HomologousBone Marrow CellsLiver TransplantationGraft vs Host DiseaseTransplantation, AutologousHematopoietic Stem Cell TransplantationKidney TransplantationWhole-Body IrradiationBone and BonesAnemia, AplasticTransplantation ConditioningLiving DonorsLeukemiaTissue and Organ ProcurementTransplantation ChimeraRetrospective StudiesTissue DonorsGraft SurvivalTreatment OutcomeBusulfanBone Marrow PurgingHistocompatibility TestingHematopoietic Stem CellsHistocompatibilityCyclophosphamideTransplantation, IsogeneicBone Marrow DiseasesHematopoiesisRecurrenceCombined Modality TherapyRadiation ChimeraMice, Inbred C57BLLeukemia, Myelogenous, Chronic, BCR-ABL PositiveBone Marrow ExaminationLeukemia, Myeloid, AcuteImmunosuppressive AgentsRemission InductionGraft RejectionHematologic NeoplasmsTime FactorsPrecursor Cell Lymphoblastic Leukemia-LymphomaHepatic Veno-Occlusive DiseaseBone RemodelingBone Marrow NeoplasmsTransplantation ImmunologyGraft vs Host ReactionLeukemia, MyeloidImmunosuppressionLymphocyte DepletionStem Cell TransplantationLymphoma, Non-HodgkinLeukocyte TransfusionAcute DiseaseHeart TransplantationSevere Combined ImmunodeficiencySurvival AnalysisChimeraT-LymphocytesColony-Forming Units AssayHLA AntigensMyelodysplastic SyndromesLung TransplantationActuarial AnalysisCyclosporineBone DensityHematologic DiseasesLymphocyte TransfusionAntineoplastic Combined Chemotherapy ProtocolsNuclear FamilyCarmustineOrgan TransplantationFollow-Up StudiesPancytopeniaCell DifferentiationGraft vs Tumor EffectSurvival RateGraft vs Leukemia EffectCytarabineLeukocyte CountCytomegalovirus InfectionsSpleenBone ResorptionGranulocyte Colony-Stimulating FactorMelphalanDisease-Free SurvivalMice, Inbred BALB CEtoposideFlow CytometryLymphomaMultiple MyelomaCells, CulturedFatal OutcomePrognosisHodgkin DiseaseAntigens, CD34Mice, KnockoutInfectionCell Transplantation